Mabwell’s groundbreaking anti-IL-11 antibody enters Phase II trials for pathological scarring
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
His professional background also includes key experience at Matrix Labs and Sun Pharma
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The Co-Dx PCR platform is designed to deliver gold-standard PCR accuracy in a compact, user-friendly device suitable for decentralized testing environments
Subscribe To Our Newsletter & Stay Updated